Edwards Lifesciences Enterprise Value over EBITDA Trend

Edwards Lifesciences Corporation -- USA Stock  

USD 120.07  0.76  0.63%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Enterprise Value over EBITDA of Edwards Lifesciences Corporation with missing and latest data points interpolated. Measures the ratio between Enterprise Value and Earnings Before Interest Taxes and Depreciation Amortization USD.
Enterprise Value over EBITDA  10 Years Trend  
Increasing
Stable
 Enterprise Value over EBITDA 
      Timeline 

Edwards Lifesciences Enterprise Value over EBITDA Over Time

2016-12-31  24.13 
2017-12-31  24.13 
2018-12-31  25.38 

Other Fundumenentals

 

Regression Statistics

Arithmetic Mean  20.07
Geometric Mean  19.01
Coefficient Of Variation  32.02
Mean Deviation  5.84
Median  23.02
Standard Deviation  6.43
Sample Variance  41.3
Range  16.48
R Value  0.26
Mean Square Error  41.98
R Squared  0.068195
Significance  0.39
Slope  0.43
Total Sum of Squares  495.61

Currently Trending

MSFT   
 NMS 
Purchased over 30 shares of
few hours ago ago
Traded for 89.58
TWTR   
 NYQ 
Purchased over 100 shares of
few hours ago ago
Traded for 25.41
VMW   
 NYQ 
Purchased over 20 shares of
few hours ago ago
Traded for 132.53